Transgenomic Inc Stock Nasdaq
Equities
US89365K3059
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 01 | Transcript : Precipio, Inc. - Special Call | |
Mar. 29 | Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 9.41M | Sales 2023 | 15.2M | Capitalization | 9.23M |
---|---|---|---|---|---|
Net income 2022 | -12M | Net income 2023 | -5M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M | Net cash position 2023 | 386K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 95.57% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 80 | 19-12-02 |
1st Jan change | Capi. | |
---|---|---|
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |